Valo Health, Inc. ("Valo"), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly ...

Despite the medical advances of the modern age, more than 300 million people around the world still suffer from diseases for which there are no cures. Many cancers remain a death sentence. Alzheimer’s ...

According to CEO Helen Gu, the biggest problem facing the industry today is not just monitoring and diagnosing where AI ...

MONTREAL, April 7, 2026 /CNW/ - Sorintellis today announced a new strategic scientific collaboration aimed at advancing its intelligence infrastructure for clinical trial decision-making, powered by ...

BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence and machine learning to turn complex biomedical data into ...

By observing how health data changes over time, artificial intelligence can help identify “tipping points” when a patient’s ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

The next major advance in medical AI may lie not in analyzing more data, but in understanding how health data change over time. A recent editorial in Intelligent Medicine argues that dynamics-driven ...

National Public Health Week offered students at the Brown University School of Public Health the opportunity to discuss the ...

Specific combinations of CT imaging features rather than individual findings alone may improve the accuracy of identifying ...

Commercial agreement serves as high-profile third party validation of BullFrog AI’s proprietary capabilities Agreement utilizes BullFrog AI’s end-to-end analytical AI platform to accelerate drug ...